Clinical Trial

A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind, placebo-controlled, multiple-ascending-dose study of SN2001 in healthy adult subjects. The study is designed to evaluate the safety, tolerability and immunogenicity of SN2001.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-08.
Status change: Not Yet Recruiting → Recruiting 2025-08-19
Trial Details
NCT Number NCT07059403
Lead Sponsor Chimivac INC
Conditions Chronic Hepatitis B Infection
Enrollment 36 participants
Start Date 2025-08-19
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-08-24